http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 11 Feb 2026 07:00:00 +0000 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Halcones+Precious+Metals+Announces+Approval+of+Warrants+Extension/25979189.html <p align="justify">TORONTO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Halcones Precious Metals Corp. (TSXV: HPM) (the “<strong>Company</strong>” or “<strong>Halcones</strong>”) announces that the TSX Venture Exchange has approved the extension of the expiry dates of a total of 61,759,638 common share purchase warrants (the <strong>“Warrants”</strong>). Each Warrant entitles the holder thereof to acquire one common share of the Company at a price of $0.10 per common share. All other terms of the Warrants, including exercise price, will remain the same. The Warrants were issued pursuant to the following private placements:</p> <ul type="disc"><li style="margin-top:9.75pt; margin-bottom:9.75pt; text-align:justify;">30,481,462 common share purchase warrants http://www.streetinsider.com/Press+Releases/Halcones+Precious+Metals+Announces+Approval+of+Warrants+Extension/25979189.html Wed, 11 Feb 2026 07:00:00 +0000 A.36078215 HPM O.02555813 O.46878772 http://www.streetinsider.com/Press+Releases/Halcones+Precious+Metals+Announces+Approval+of+Warrants+Extension/25979189.html <p align="justify">TORONTO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Halcones Precious Metals Corp. (TSXV: HPM) (the “<strong>Company</strong>” or “<strong>Halcones</strong>”) announces that the TSX Venture Exchange has approved the extension of the expiry dates of a total of 61,759,638 common share purchase warrants (the <strong>“Warrants”</strong>). Each Warrant entitles the holder thereof to acquire one common share of the Company at a price of $0.10 per common share. All other terms of the Warrants, including exercise price, will remain the same. The Warrants were issued pursuant to the following private placements:</p> <ul type="disc"><li style="margin-top:9.75pt; margin-bottom:9.75pt; text-align:justify;">30,481,462 common share purchase warrants http://www.streetinsider.com/Press+Releases/Halcones+Precious+Metals+Announces+Approval+of+Warrants+Extension/25979189.html Wed, 11 Feb 2026 07:00:00 +0000 A.36078215 HPM O.02555813 O.46878772 http://www.streetinsider.com/Press+Releases/Halcones+Precious+Metals+Announces+Approval+of+Warrants+Extension/25979189.html <p align="justify">TORONTO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Halcones Precious Metals Corp. (TSXV: HPM) (the “<strong>Company</strong>” or “<strong>Halcones</strong>”) announces that the TSX Venture Exchange has approved the extension of the expiry dates of a total of 61,759,638 common share purchase warrants (the <strong>“Warrants”</strong>). Each Warrant entitles the holder thereof to acquire one common share of the Company at a price of $0.10 per common share. All other terms of the Warrants, including exercise price, will remain the same. The Warrants were issued pursuant to the following private placements:</p> <ul type="disc"><li style="margin-top:9.75pt; margin-bottom:9.75pt; text-align:justify;">30,481,462 common share purchase warrants http://www.streetinsider.com/Press+Releases/Halcones+Precious+Metals+Announces+Approval+of+Warrants+Extension/25979189.html Wed, 11 Feb 2026 07:00:00 +0000 A.36078215 HPM O.02555813 O.46878772 http://www.streetinsider.com/Press+Releases/Halcones+Precious+Metals+Announces+Approval+of+Warrants+Extension/25979189.html <p align="justify">TORONTO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Halcones Precious Metals Corp. (TSXV: HPM) (the “<strong>Company</strong>” or “<strong>Halcones</strong>”) announces that the TSX Venture Exchange has approved the extension of the expiry dates of a total of 61,759,638 common share purchase warrants (the <strong>“Warrants”</strong>). Each Warrant entitles the holder thereof to acquire one common share of the Company at a price of $0.10 per common share. All other terms of the Warrants, including exercise price, will remain the same. The Warrants were issued pursuant to the following private placements:</p> <ul type="disc"><li style="margin-top:9.75pt; margin-bottom:9.75pt; text-align:justify;">30,481,462 common share purchase warrants http://www.streetinsider.com/Press+Releases/Halcones+Precious+Metals+Announces+Approval+of+Warrants+Extension/25979189.html Wed, 11 Feb 2026 07:00:00 +0000 A.36078215 HPM O.02555813 O.46878772 http://www.streetinsider.com/Globe+Newswire/Halcones+Precious+Metals+Announces+Approval+of+Warrants+Extension/25979189.html <p align="justify">TORONTO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Halcones Precious Metals Corp. (TSXV: HPM) (the “<strong>Company</strong>” or “<strong>Halcones</strong>”) announces that the TSX Venture Exchange has approved the extension of the expiry dates of a total of 61,759,638 common share purchase warrants (the <strong>“Warrants”</strong>). Each Warrant entitles the holder thereof to acquire one common share of the Company at a price of $0.10 per common share. All other terms of the Warrants, including exercise price, will remain the same. The Warrants were issued pursuant to the following private placements:</p> <ul type="disc"><li style="margin-top:9.75pt; margin-bottom:9.75pt; text-align:justify;">30,481,462 common share purchase warrants http://www.streetinsider.com/Globe+Newswire/Halcones+Precious+Metals+Announces+Approval+of+Warrants+Extension/25979189.html Wed, 11 Feb 2026 07:00:00 +0000 A.36078215 HPM O.02555813 O.46878772 http://www.streetinsider.com/Globe+Newswire/Halcones+Precious+Metals+Announces+Approval+of+Warrants+Extension/25979189.html <p align="justify">TORONTO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Halcones Precious Metals Corp. (TSXV: HPM) (the “<strong>Company</strong>” or “<strong>Halcones</strong>”) announces that the TSX Venture Exchange has approved the extension of the expiry dates of a total of 61,759,638 common share purchase warrants (the <strong>“Warrants”</strong>). Each Warrant entitles the holder thereof to acquire one common share of the Company at a price of $0.10 per common share. All other terms of the Warrants, including exercise price, will remain the same. The Warrants were issued pursuant to the following private placements:</p> <ul type="disc"><li style="margin-top:9.75pt; margin-bottom:9.75pt; text-align:justify;">30,481,462 common share purchase warrants http://www.streetinsider.com/Globe+Newswire/Halcones+Precious+Metals+Announces+Approval+of+Warrants+Extension/25979189.html Wed, 11 Feb 2026 07:00:00 +0000 A.36078215 HPM O.02555813 O.46878772 http://www.streetinsider.com/Globe+Newswire/Halcones+Precious+Metals+Announces+Approval+of+Warrants+Extension/25979189.html <p align="justify">TORONTO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Halcones Precious Metals Corp. (TSXV: HPM) (the “<strong>Company</strong>” or “<strong>Halcones</strong>”) announces that the TSX Venture Exchange has approved the extension of the expiry dates of a total of 61,759,638 common share purchase warrants (the <strong>“Warrants”</strong>). Each Warrant entitles the holder thereof to acquire one common share of the Company at a price of $0.10 per common share. All other terms of the Warrants, including exercise price, will remain the same. The Warrants were issued pursuant to the following private placements:</p> <ul type="disc"><li style="margin-top:9.75pt; margin-bottom:9.75pt; text-align:justify;">30,481,462 common share purchase warrants http://www.streetinsider.com/Globe+Newswire/Halcones+Precious+Metals+Announces+Approval+of+Warrants+Extension/25979189.html Wed, 11 Feb 2026 07:00:00 +0000 A.36078215 HPM O.02555813 O.46878772 http://www.streetinsider.com/Globe+Newswire/Halcones+Precious+Metals+Announces+Approval+of+Warrants+Extension/25979189.html <p align="justify">TORONTO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Halcones Precious Metals Corp. (TSXV: HPM) (the “<strong>Company</strong>” or “<strong>Halcones</strong>”) announces that the TSX Venture Exchange has approved the extension of the expiry dates of a total of 61,759,638 common share purchase warrants (the <strong>“Warrants”</strong>). Each Warrant entitles the holder thereof to acquire one common share of the Company at a price of $0.10 per common share. All other terms of the Warrants, including exercise price, will remain the same. The Warrants were issued pursuant to the following private placements:</p> <ul type="disc"><li style="margin-top:9.75pt; margin-bottom:9.75pt; text-align:justify;">30,481,462 common share purchase warrants http://www.streetinsider.com/Globe+Newswire/Halcones+Precious+Metals+Announces+Approval+of+Warrants+Extension/25979189.html Wed, 11 Feb 2026 07:00:00 +0000 A.36078215 HPM O.02555813 O.46878772 http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html <p align="justify" style="padding-left:0pt;">TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- <strong>NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)</strong>, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).</p> <p align="justify" style="padding-left:0pt;">Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.</p> <p align="justify" style="padding-left:0pt;">Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html Thu, 29 Jan 2026 08:30:00 +0000 A.02865479 A.23610225 A.38374316 A.50214698 AIAI AINMF EMO HPM LTH NBLC O.00392811 O.01688568 O.05079513 O.09232287 O.19741769 O.34925378 O.46878772 O.52416069 O.54441446 PF0 http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html <p align="justify" style="padding-left:0pt;">TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- <strong>NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)</strong>, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).</p> <p align="justify" style="padding-left:0pt;">Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.</p> <p align="justify" style="padding-left:0pt;">Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html Thu, 29 Jan 2026 08:30:00 +0000 A.02865479 A.23610225 A.38374316 A.50214698 AIAI AINMF EMO HPM LTH NBLC O.00392811 O.01688568 O.05079513 O.09232287 O.19741769 O.34925378 O.46878772 O.52416069 O.54441446 PF0 http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html <p align="justify" style="padding-left:0pt;">TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- <strong>NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)</strong>, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).</p> <p align="justify" style="padding-left:0pt;">Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.</p> <p align="justify" style="padding-left:0pt;">Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html Thu, 29 Jan 2026 08:30:00 +0000 A.02865479 A.23610225 A.38374316 A.50214698 AIAI AINMF EMO HPM LTH NBLC O.00392811 O.01688568 O.05079513 O.09232287 O.19741769 O.34925378 O.46878772 O.52416069 O.54441446 PF0 http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html <p align="justify" style="padding-left:0pt;">TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- <strong>NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)</strong>, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).</p> <p align="justify" style="padding-left:0pt;">Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.</p> <p align="justify" style="padding-left:0pt;">Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html Thu, 29 Jan 2026 08:30:00 +0000 A.02865479 A.23610225 A.38374316 A.50214698 AIAI AINMF EMO HPM LTH NBLC O.00392811 O.01688568 O.05079513 O.09232287 O.19741769 O.34925378 O.46878772 O.52416069 O.54441446 PF0 http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html <p align="justify" style="padding-left:0pt;">TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- <strong>NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)</strong>, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).</p> <p align="justify" style="padding-left:0pt;">Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.</p> <p align="justify" style="padding-left:0pt;">Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html Thu, 29 Jan 2026 08:30:00 +0000 A.02865479 A.23610225 A.38374316 A.50214698 AIAI AINMF EMO HPM LTH NBLC O.00392811 O.01688568 O.05079513 O.09232287 O.19741769 O.34925378 O.46878772 O.52416069 O.54441446 PF0 http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html <p align="justify" style="padding-left:0pt;">TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- <strong>NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)</strong>, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).</p> <p align="justify" style="padding-left:0pt;">Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.</p> <p align="justify" style="padding-left:0pt;">Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html Thu, 29 Jan 2026 08:30:00 +0000 A.02865479 A.23610225 A.38374316 A.50214698 AIAI AINMF EMO HPM LTH NBLC O.00392811 O.01688568 O.05079513 O.09232287 O.19741769 O.34925378 O.46878772 O.52416069 O.54441446 PF0 http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html <p align="justify" style="padding-left:0pt;">TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- <strong>NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)</strong>, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).</p> <p align="justify" style="padding-left:0pt;">Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.</p> <p align="justify" style="padding-left:0pt;">Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html Thu, 29 Jan 2026 08:30:00 +0000 A.02865479 A.23610225 A.38374316 A.50214698 AIAI AINMF EMO HPM LTH NBLC O.00392811 O.01688568 O.05079513 O.09232287 O.19741769 O.34925378 O.46878772 O.52416069 O.54441446 PF0 http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html <p align="justify" style="padding-left:0pt;">TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- <strong>NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)</strong>, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).</p> <p align="justify" style="padding-left:0pt;">Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.</p> <p align="justify" style="padding-left:0pt;">Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html Thu, 29 Jan 2026 08:30:00 +0000 A.02865479 A.23610225 A.38374316 A.50214698 AIAI AINMF EMO HPM LTH NBLC O.00392811 O.01688568 O.05079513 O.09232287 O.19741769 O.34925378 O.46878772 O.52416069 O.54441446 PF0 http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html <p align="justify" style="padding-left:0pt;">TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- <strong>NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)</strong>, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).</p> <p align="justify" style="padding-left:0pt;">Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.</p> <p align="justify" style="padding-left:0pt;">Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html Thu, 29 Jan 2026 08:30:00 +0000 A.02865479 A.23610225 A.38374316 A.50214698 AIAI AINMF EMO HPM LTH NBLC O.00392811 O.01688568 O.05079513 O.09232287 O.19741769 O.34925378 O.46878772 O.52416069 O.54441446 PF0 http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html <p align="justify" style="padding-left:0pt;">TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- <strong>NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)</strong>, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).</p> <p align="justify" style="padding-left:0pt;">Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.</p> <p align="justify" style="padding-left:0pt;">Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html Thu, 29 Jan 2026 08:30:00 +0000 A.02865479 A.23610225 A.38374316 A.50214698 AIAI AINMF EMO HPM LTH NBLC O.00392811 O.01688568 O.05079513 O.09232287 O.19741769 O.34925378 O.46878772 O.52416069 O.54441446 PF0 http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html <p align="justify" style="padding-left:0pt;">TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- <strong>NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)</strong>, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).</p> <p align="justify" style="padding-left:0pt;">Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.</p> <p align="justify" style="padding-left:0pt;">Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html Thu, 29 Jan 2026 08:30:00 +0000 A.02865479 A.23610225 A.38374316 A.50214698 AIAI AINMF EMO HPM LTH NBLC O.00392811 O.01688568 O.05079513 O.09232287 O.19741769 O.34925378 O.46878772 O.52416069 O.54441446 PF0 http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html <p align="justify" style="padding-left:0pt;">TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- <strong>NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)</strong>, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).</p> <p align="justify" style="padding-left:0pt;">Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.</p> <p align="justify" style="padding-left:0pt;">Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html Thu, 29 Jan 2026 08:30:00 +0000 A.02865479 A.23610225 A.38374316 A.50214698 AIAI AINMF EMO HPM LTH NBLC O.00392811 O.01688568 O.05079513 O.09232287 O.19741769 O.34925378 O.46878772 O.52416069 O.54441446 PF0 http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html <p align="justify" style="padding-left:0pt;">TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- <strong>NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)</strong>, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).</p> <p align="justify" style="padding-left:0pt;">Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.</p> <p align="justify" style="padding-left:0pt;">Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html Thu, 29 Jan 2026 08:30:00 +0000 A.02865479 A.23610225 A.38374316 A.50214698 AIAI AINMF EMO HPM LTH NBLC O.00392811 O.01688568 O.05079513 O.09232287 O.19741769 O.34925378 O.46878772 O.52416069 O.54441446 PF0 http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html <p align="justify" style="padding-left:0pt;">TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- <strong>NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)</strong>, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).</p> <p align="justify" style="padding-left:0pt;">Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.</p> <p align="justify" style="padding-left:0pt;">Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html Thu, 29 Jan 2026 08:30:00 +0000 A.02865479 A.23610225 A.38374316 A.50214698 AIAI AINMF EMO HPM LTH NBLC O.00392811 O.01688568 O.05079513 O.09232287 O.19741769 O.34925378 O.46878772 O.52416069 O.54441446 PF0 http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html <p align="justify" style="padding-left:0pt;">TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- <strong>NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)</strong>, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).</p> <p align="justify" style="padding-left:0pt;">Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.</p> <p align="justify" style="padding-left:0pt;">Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html Thu, 29 Jan 2026 08:30:00 +0000 A.02865479 A.23610225 A.38374316 A.50214698 AIAI AINMF EMO HPM LTH NBLC O.00392811 O.01688568 O.05079513 O.09232287 O.19741769 O.34925378 O.46878772 O.52416069 O.54441446 PF0 http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html <p align="justify" style="padding-left:0pt;">TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- <strong>NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)</strong>, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).</p> <p align="justify" style="padding-left:0pt;">Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.</p> <p align="justify" style="padding-left:0pt;">Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html Thu, 29 Jan 2026 08:30:00 +0000 A.02865479 A.23610225 A.38374316 A.50214698 AIAI AINMF EMO HPM LTH NBLC O.00392811 O.01688568 O.05079513 O.09232287 O.19741769 O.34925378 O.46878772 O.52416069 O.54441446 PF0 http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html <p align="justify" style="padding-left:0pt;">TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- <strong>NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0)</strong>, a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”).</p> <p align="justify" style="padding-left:0pt;">Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-company governance.</p> <p align="justify" style="padding-left:0pt;">Mr. Guy is currently a Managing Director with Next Edge Capital, an investment fund manager, where he focuses on strategic http://www.streetinsider.com/Press+Releases/NetraMark+Strengthens+Board+Of+Directors/25912760.html Thu, 29 Jan 2026 08:30:00 +0000 A.02865479 A.23610225 A.38374316 A.50214698 AIAI AINMF EMO HPM LTH NBLC O.00392811 O.01688568 O.05079513 O.09232287 O.19741769 O.34925378 O.46878772 O.52416069 O.54441446 PF0